Current Oncology, Free Full-Text
Por um escritor misterioso
Last updated 02 outubro 2024
Background: Information on immune responses in cancer patients following mRNA COVID-19 vaccines is still insufficient, but generally, patients had impaired serological responses, especially those with hematological malignancies. We evaluated serological response to COVID-19 mRNA vaccine in cancer patients receiving chemotherapy compared with healthy controls. Methods: In total, 195 cancer patients and 400 randomly selected controls who had been administered a Pfizer-BioNTech or Moderna COVID-19 vaccines in two doses were compared. The threshold of positivity was 4.33 BAU/mL. Patients were receiving anticancer treatment after the first and second dose of the vaccines. Results: a TOTAL OF 169 patients (87%) had solid tumors and 26 hemolymphopoietic diseases. Seropositivity rate was lower in patients than controls (91% vs. 96%), with an age/gender-adjusted rate ratio (RR) of 0.95 (95% CL = 0.89–1.02). Positivity was found in 97% of solid cancers and in 50% of hemolymphopoietic tumors. Both advanced and adjuvant therapy seemed to slightly reduce seropositivity rates in patients when compared to controls (RR = 0.97, 95% CL = 0.89–1.06; RR = 0.94, 95% CL = 0.87–1.01). Conclusions: the response to vaccination is similar in patients affected by solid tumors to controls. On the contrary, hemolymphopietic patients show a much lower response than controls.
Dr. Susan Love's Breast Book: Love MD, Susan M., Love, Elizabeth: 9780306833250: : Books
British Neuro-Oncology Society
touchONCOLOGY - Online Education for Oncology Professionals
Cancer Investigation: Vol 41, No 9 (Current issue)
Free Oncology CE and CME for Healthcare Professionals
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
Home Page: Journal of Thoracic Oncology
Home Page: Clinical Oncology
Printable Cancer Visit Notes Sheet Medical Appointment
National Comprehensive Cancer Network - Home
Malignant: How Bad Policy and Bad by Prasad, Vinayak K.
The Lancet Oncology
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Recomendado para você
-
Bronstein: Agendamento online de exames e vacinas pelo Nav02 outubro 2024
-
Dominion Lawyers Launch New Firm, Bringing High-Profile Defamation02 outubro 2024
-
Meet the Defamation Lawyer Combating Online Harassment Campaigns02 outubro 2024
-
Coronavírus: Exame de PCR para COVID-19 no RJ02 outubro 2024
-
Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression02 outubro 2024
-
The Supreme Court Can Correct a Life or Death Injustice for Terence Andrus02 outubro 2024
-
Gamma Knife radiosurgery for acromegaly: Evaluating the role of02 outubro 2024
-
Gmail - Confirmação de Agendamento - Bronstein Medicina Diagnóstica02 outubro 2024
-
Bronstein - RM, Já imaginou um exame que pode detalhar todos os tecidos do corpo em imagem, detectar cânceres, mapear a atividade cerebral e, ao contrário do raio-X, não02 outubro 2024
-
These testimonies speak for themselves. #cyberbullyingkills02 outubro 2024
você pode gostar
-
Raça Negra: música, letras, canciones, discos02 outubro 2024
-
Max level + light awakening in king legacy #roblox #kinglegacy02 outubro 2024
-
The Fuzz Ball - GTA 3 Guide - IGN02 outubro 2024
-
Free Fire: Coach Batman destrincha atualização e explica novo meta02 outubro 2024
-
Karsten Johansson - FamousFix.com02 outubro 2024
-
Boruto e naruto #naruto #uzumaki #boruto #animes #otakus #anime #anime02 outubro 2024
-
Desire - The game for couples for Android - Download02 outubro 2024
-
Vídeos de Comédia os melhores vídeos da internet #videos engraçados : u/AdComplex740102 outubro 2024
-
Assistir Kakegurui Dublado Todos os Episódios Online02 outubro 2024
-
IDADE INFLUENCIA NO DESEMPENHO? FAKER RESPONDE02 outubro 2024